tiprankstipranks
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market
8YY
Biolidics Ltd.
RESEARCH TOOLSreports

Biolidics Ltd. (8YY) Income Statement

2 Followers

Biolidics Ltd. Income Statement

Last quarter (Q4 2025), Biolidics Ltd.'s total revenue was S$3.51M, an increase of 24950.00% from the same quarter last year. In Q4, Biolidics Ltd.'s net income was S$-3.34M. See Biolidics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
S$ 5.26MS$ 784.00KS$ 277.00KS$ 2.49MS$ 2.31M
Gross Profit
S$ 1.94MS$ 187.00KS$ 146.00KS$ 1.16MS$ 483.00K
Operating Expenses
S$ 5.16MS$ 1.89MS$ 1.14MS$ 4.20MS$ 3.79M
Depreciation and Amortization
S$ 263.00KS$ 120.00KS$ 241.00KS$ 1.18MS$ 1.25M
EBITDA
S$ -3.65MS$ -3.03MS$ -1.16MS$ -8.50MS$ -4.58M
Operating Income
S$ -3.22MS$ -1.70MS$ -996.00KS$ -3.04MS$ -3.31M
Other Income/Expenses
S$ -772.00KS$ -1.49MS$ -518.00KS$ -6.82MS$ -2.73M
Pretax Income
S$ -3.99MS$ -3.19MS$ -1.51MS$ -9.85MS$ -6.04M
Net Income
S$ -3.96MS$ -3.43MS$ -2.49MS$ -9.37MS$ -5.98M
Per Share Metrics
Basic EPS
S$ >-0.01S$ 0.00S$ 0.00S$ -0.03S$ -0.02
Diluted EPS
S$ >-0.01S$ 0.00S$ 0.00S$ -0.03S$ -0.02
Weighted Average Shares Outstanding
 1.71B 981.26M 593.13M 281.69M 264.99M
Weighted Average Shares Outstanding (Diluted)
 1.71B 981.26M 593.13M 281.69M 265.21M
Currency in SGD

Biolidics Ltd. Earnings and Revenue History